We've sent out thousands of our 'Man of Men' Christmas decorations to people who've donated to our Christmas appeal. Donors are using them to remember loved ones and show their support for us by hanging them on their tree. Find out what Sky Sports presenter and fundraiser extraordinaire Jeff Stelling wrote on his, and how to receive yours in time for Christmas.
After her dad was successfully treated for prostate cancer, Zoe Hegarty and her husband decided to use their nuptials to raise money and awareness of the disease. She tells us how the wedding guests reacted and why she'd encourage others to Donate your day for Prostate Cancer UK.
A year after their QPR-loving father died from advanced prostate cancer, Amy Corbett and her brother, Simon, came up with the perfect way to commemorate and celebrate his life: a football fun day fundraiser. She tells us about what happened and why raising awareness was as important as the £5k they donated from the event to Prostate Cancer UK.
BLOG: From training up radiologists to working alongside commissioners and the NHS, Dr Sophie Lutter explains how we're making sure the results of the PROMIS trial are rolled out into real-life hospitals as soon as they've been peer-reviewed, and why rushing it could do more harm than good.
Funded by us, Lucy Baker works as a Specialist Prostate Cancer Palliative Care Nurse supporting men in their final year of life. Here she describes how her role helped three men deal with the pain, anxiety and immobility of their disease.
BLOG: The revolutionary ADRRAD trial turns conventional thinking about advanced prostate cancer on its head, attempting to overcome a disease that's considered terminal. Dr Sophie Lutter looks behind the scenes at what makes this such a game-changing enterprise and why it represents the perfect dance between medicine and science.
Professor Robert Winston chaired a panel of leading cancer specialists last night to discuss how our new 10-year strategy to tame prostate cancer can be turned into clinical reality. From robotic surgery to genetic testing, here’s what the experts say will work.
Today, we announce plans for more than £2m of funding to develop a new risk assessment tool for GPs that should indicate the presence of cancer far more accurately than the current PSA test, saving thousands more men's lives.
Our £1.5m of Movember Foundation Translational Awards will ensure four groundbreaking projects make it through the labs and into clinical trials.
Meet the vital clinical staff we fund, with support from Movember, to help smooth and improve the process of treatment for men with prostate cancer.